|
Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
Eur J Anaesthesiol. 2009 Dic; Epub ahead of print Ene
Zisman E, Erport A, Kohanovsky E, Ballagulah M, Cassel A, Quitt M, Pizov R. |
|
Antiplatelet and Anticoagulant Therapies in Acute Coronary Syndromes.
Cardiovasc Drugs Ther. . 2009 Dic; Epub ahead of print Ene
Hanna EB, Glancy DL, Saucedo JF. |
|
Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome.
Int J Med Sci. 2009 Dic; 7(1):15-8.
Okuma H, Kitagawa Y, Yasuda T, Tokuoka K, Takagi S. |
|
Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
J Am Coll Cardiol. 2009 Sep; 54(13):1149-1153.
Cuisset T, Frere C, Quilici J, Poyet R, Gaborit B, Bali L, Brissy O, Morange PE, Alessi MC, Bonnet JL. |
|
Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.
Blood. 2009 Sep; Epub ahead of print Ene
Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. |
|
Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization.
J Allergy Clin Immunol. 2009 Sep; Epub ahead of print Ene
Steinke JW, Culp JA, Kropf E, Borish L. |
|
Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese.
Hypertens Res. 2009 Sep; Epub ahead of print Ene
Miwa Y, Kamide K, Takiuchi S, Yoshii M, Horio T, Tanaka C, Banno M, Miyata T, Kawano Y. |
|
Aspirin for prevention of stroke and cardiovascular events among patients with peripheral artery disease.
JAMA. 2009 Sep; 302(11):1165-6. Author reply Ene
Takagi H, Umemoto T. |
|
Effect of the Thromboxane Prostaglandin Receptor Antagonist Terutroban on Arterial Thrombogenesis after Repeated Administration in Patients Treated for the Prevention of Ischemic Stroke
Cerebrovasc Dis. 2009 Sep; 28(5):505-513. Epub ahead of print Ene
Bal Dit Sollier C, Crassard I, Simoneau G, Bergmann JF, Bousser MG, Drouet L. |
|
Oxidative Risk for Atherothrombotic Cardiovascular Disease.
Free Radic Biol Med. 2009 Sep; Epub ahead of print Ene
Leopold JA, Loscalzo J. |
|
Stroke and aspirin non-responder patients: Relation with hypertension and platelet response to adenosine diphosphate.
Platelets. 2009 Sep; 14:1-7. Epub ahead of print Ene
Godeneche G, Sorel N, Ragot S, Chomel JC, Neau JP, Macchi L. |
|
Neonatal and pregnancy outcome in primary antiphospholipid syndrome: a 10-year experience in one medical center.
Pediatr Neonatol. 2009 Ago; 50(4):143-146.
Chou AK, Hsieh SC, Su YN, Jeng SF, Chen CY, Chou HC, Tsao PN, Hsieh WS. |
|
Clopidogrel resistance "Live" - the risk of stent thrombosis should be evaluated before procedures.
Thromb J. 2009 May; 19(7):1-6. Epub ahead of print Ene
Motovska Z, Widimsky P, Marinov I, Petr R, Hajkova J, Kvasnicka J, Study Investigators P. |
|
Risk Factors for Major Bleeding and for Minor Bleeding After Percutaneous Coronary Intervention in 634 Consecutive Patients With Acute Coronary Syndromes.
Am J Ther. 2009 May; Epub ahead of print
Pierre-Louis B, Aronow WS, Yoon JH, Ahn C, Kalapatapu K, Pucillo AL, Monsen CE. |
|
Antiplatelet drug ´resistance´. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?
Nat Rev Cardiol. 2009 May; 6(5):365-73. Epub 2009 Abr 14
Gorog DA, Sweeny JM, Fuster V. |
|
Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease.
Curr Atheroscler Rep. 2009 May; 11(3):227-35.
Gleim S, Kasza Z, Martin K, Hwa J. |
|
Use of Antithrombotic Drugs and the Presence of Cerebral Microbleeds: The Rotterdam Scan Study.
Arch Neurol. 2009 Abr; Epub ahead of print
Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, Breteler MM. |
|
Dual Antiplatelet Drug Resistance Is a Risk Factor for Cardiovascular Events after Percutaneous Coronary Intervention.
Clin Chem. 2009 Abr;
Ivandic BT, Sausemuth M, Ibrahim H, Giannitsis E, Gawaz M, Katus HA. |
|
Comorbidity between depression and cardiovascular disease.
Int Angiol. 2009 Abr; 28(2):92-9.
Halaris A. |
|
Platelet hyperreactivity in response to on- and off-pump coronary artery bypass grafting.
J Extra Corpor Technol. 2009 Mar; 41(1):15-19.
Bochsen L, Rosengaard LB, Nielsen AB, Steinbrüchel DA, Johansson PI. |
